Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
US9925189B2 · kind B2 · utility
0Cited by
52References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2017 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Jul 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.